Resistance to BRAF/MEK Inhibition in Melanoma Is Mediated by the Androgen Receptor
- PMID: 35748587
- DOI: 10.1158/2159-8290.CD-RW2022-114
Resistance to BRAF/MEK Inhibition in Melanoma Is Mediated by the Androgen Receptor
Abstract
Androgen receptor (AR) expression increases upon BRAF/MEK inhibitor treatment, promoting resistance.
©2022 American Association for Cancer Research.
Comment on
-
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.Nature. 2022 Jun;606(7915):797-803. doi: 10.1038/s41586-022-04833-8. Epub 2022 Jun 15. Nature. 2022. PMID: 35705814 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
